Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 108

1.

Erratum to: 'Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice'.

Napp LC, Jabs O, Höckelmann A, Dutzmann J, Kapopara PR, Sedding DG, Gaestel M, Bauersachs J, Bavendiek U.

Vasc Cell. 2016 Dec 23;9:1. doi: 10.1186/s13221-016-0039-1. eCollection 2017.

2.

Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice.

Napp LC, Jabs O, Höckelmann A, Dutzmann J, Kapopara PR, Sedding DG, Gaestel M, Bauersachs J, Bavendiek U.

Vasc Cell. 2016 Oct 21;8:4. doi: 10.1186/s13221-016-0038-2. eCollection 2016. Erratum in: Vasc Cell. 2016 Dec 23;9:1.

3.

Angiogenic and anti-inflammatory properties of micro-fragmented fat tissue and its derived mesenchymal stromal cells.

Ceserani V, Ferri A, Berenzi A, Benetti A, Ciusani E, Pascucci L, Bazzucchi C, Coccè V, Bonomi A, Pessina A, Ghezzi E, Zeira O, Ceccarelli P, Versari S, Tremolada C, Alessandri G.

Vasc Cell. 2016 Aug 18;8:3. doi: 10.1186/s13221-016-0037-3. eCollection 2016.

4.

A novel endothelial-derived anti-inflammatory activity significantly inhibits spontaneous choroidal neovascularisation in a mouse model.

Paneghetti L, Ng YS.

Vasc Cell. 2016 May 11;8:2. doi: 10.1186/s13221-016-0036-4. eCollection 2016.

5.

A novel mutation in CELSR1 is associated with hereditary lymphedema.

Gonzalez-Garay ML, Aldrich MB, Rasmussen JC, Guilliod R, Lapinski PE, King PD, Sevick-Muraca EM.

Vasc Cell. 2016 Feb 5;8:1. doi: 10.1186/s13221-016-0035-5. eCollection 2016.

6.

Vascular Notch proteins and Notch signaling in the peri-implantation mouse uterus.

Shawber CJ, Lin L, Gnarra M, Sauer MV, Papaioannou VE, Kitajewski JK, Douglas NC.

Vasc Cell. 2015 Dec 1;7:9. doi: 10.1186/s13221-015-0034-y. eCollection 2015.

7.

Mechanical stretch: physiological and pathological implications for human vascular endothelial cells.

Jufri NF, Mohamedali A, Avolio A, Baker MS.

Vasc Cell. 2015 Sep 18;7:8. doi: 10.1186/s13221-015-0033-z. eCollection 2015. Review.

8.

Variability in vascular smooth muscle cell stretch-induced responses in 2D culture.

Mantella LE, Quan A, Verma S.

Vasc Cell. 2015 Aug 21;7:7. doi: 10.1186/s13221-015-0032-0. eCollection 2015.

9.

Therapeutic manipulation of angiogenesis with miR-27b.

Veliceasa D, Biyashev D, Qin G, Misener S, Mackie AR, Kishore R, Volpert OV.

Vasc Cell. 2015 Jun 24;7:6. doi: 10.1186/s13221-015-0031-1. eCollection 2015.

10.

Solenopsin A and analogs exhibit ceramide-like biological activity.

Karlsson I, Zhou X, Thomas R, Smith AT, Bonner MY, Bakshi P, Banga AK, Bowen JP, Qabaja G, Ford SL, Ballard MD, Petersen KS, Li X, Chen G, Ogretmen B, Zhang J, Watkins EB, Arnold RS, Arbiser JL.

Vasc Cell. 2015 May 8;7:5. doi: 10.1186/s13221-015-0030-2. eCollection 2015.

11.

Decreased circulating and neutrophil mediated VEGF-A165 release in stable long-term cardiac transplant recipients.

Vitiello D, Chaar D, Neagoe PE, Ducharme A, Carrier M, Pelletier GB, Racine N, Liszkowski M, Sirois MG, White M.

Vasc Cell. 2015 Apr 22;7:4. doi: 10.1186/s13221-015-0029-8. eCollection 2015.

12.

Delta-like 4 mRNA is regulated by adjacent natural antisense transcripts.

Li K, Chowdhury T, Vakeel P, Koceja C, Sampath V, Ramchandran R.

Vasc Cell. 2015 Mar 24;7:3. doi: 10.1186/s13221-015-0028-9. eCollection 2015.

13.

γ-Actin plays a key role in endothelial cell motility and neovessel maintenance.

Pasquier E, Tuset MP, Sinnappan S, Carnell M, Macmillan A, Kavallaris M.

Vasc Cell. 2015 Feb 6;7:2. doi: 10.1186/s13221-014-0027-2. eCollection 2015.

14.

Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis.

George EM, Liu H, Robinson GG, Mahdi F, Perkins E, Bidwell GL 3rd.

Vasc Cell. 2015 Jan 24;7(1):1. doi: 10.1186/s13221-014-0026-3. eCollection 2015.

15.

Cellular and molecular basis of Venous insufficiency.

Pocock ES, Alsaigh T, Mazor R, Schmid-Schönbein GW.

Vasc Cell. 2014 Dec 12;6(1):24. doi: 10.1186/s13221-014-0024-5. eCollection 2014.

16.

The role of angiogenesis in the pathology of multiple sclerosis.

Lengfeld J, Cutforth T, Agalliu D.

Vasc Cell. 2014 Nov 28;6(1):23. doi: 10.1186/s13221-014-0023-6. eCollection 2014.

17.

Previously differentiated medial vascular smooth muscle cells contribute to neointima formation following vascular injury.

Herring BP, Hoggatt AM, Burlak C, Offermanns S.

Vasc Cell. 2014 Oct 1;6:21. doi: 10.1186/2045-824X-6-21. eCollection 2014.

18.

Lysosomal drug sequestration as a mechanism of drug resistance in vascular sarcoma cells marked by high CSF-1R expression.

Gorden BH, Saha J, Khammanivong A, Schwartz GK, Dickerson EB.

Vasc Cell. 2014 Oct 1;6:20. doi: 10.1186/2045-824X-6-20. eCollection 2014.

19.

Ageing and microvasculature.

Scioli MG, Bielli A, Arcuri G, Ferlosio A, Orlandi A.

Vasc Cell. 2014 Sep 16;6:19. doi: 10.1186/2045-824X-6-19. eCollection 2014. Review.

20.

Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage.

Yamamoto Y, Matsui J, Matsushima T, Obaishi H, Miyazaki K, Nakamura K, Tohyama O, Semba T, Yamaguchi A, Hoshi SS, Mimura F, Haneda T, Fukuda Y, Kamata JI, Takahashi K, Matsukura M, Wakabayashi T, Asada M, Nomoto KI, Watanabe T, Dezso Z, Yoshimatsu K, Funahashi Y, Tsuruoka A.

Vasc Cell. 2014 Sep 6;6:18. doi: 10.1186/2045-824X-6-18. eCollection 2014.

Supplemental Content

Loading ...
Support Center